跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIO-SIMVASTATIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BIO-SIMVASTATIN
Authorized
STANDARD
BIO-SIMVASTATIN
biomed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bc4393edc1451d12
Company
biomed pharma
Type
Standard
Approval Details
Approval Id
bc4393edc1451d12
Drug Approval Canada Name
BIO-SIMVASTATIN
Product Name
BIO-SIMVASTATIN
Status
Cancelled Post Market
Status Date
2023-07-26
Original Market Date
2019-09-19
Din
02484471
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.08
Atc Original
C10AA01 SIMVASTATIN
Atc Name
c 10 aa 01
Aig Number
0122415002
Company Name
biomed pharma
Company Address
1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8
Active Ingredients
SIMVASTATIN
40 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bc4393edc1451d12
Type
Standard
Back to Health Canada Approvals